Aquestive Therapeutics

COPENHAGEN, Denmark — September 17, 2026 Orbis Medicines announced a strategic collaboration and license agreement with Novo Nordisk to...

WARREN, N.J. — September 17, 2026 Aquestive Therapeutics announced the resubmission of its New Drug Application (NDA) to the...